Anna Wolska Selected Research

Fat-Restricted Diet (Diet, Fat Restricted)

1/2020

Experimental Therapeutics for Challenging Clinical Care of a Patient with an Extremely Rare Homozygous APOC2 Mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Wolska Research Topics

Disease

14	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2010
9	Hypertriglyceridemia 01/2023 - 01/2010
6	Insulin Resistance 04/2024 - 01/2010
6	Obesity 09/2023 - 10/2019
6	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2010
6	Neoplasms (Cancer) 01/2022 - 01/2009
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2023 - 01/2010
4	Heart Failure 04/2024 - 01/2024
4	Inflammation (Inflammations) 01/2023 - 11/2019
4	Atherosclerosis 01/2022 - 01/2020
3	Pancreatitis 12/2020 - 01/2017
2	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 01/2024 - 01/2016
2	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 01/2010
2	Coronary Disease (Coronary Heart Disease) 10/2019 - 01/2016
2	Hematologic Neoplasms (Hematological Malignancy) 07/2014 - 04/2009
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2014 - 07/2009
2	Skin Neoplasms (Skin Cancer) 04/2009 - 01/2009
1	Frailty 03/2024
1	Liver Diseases (Liver Disease) 01/2024
1	Hemolysis 01/2024
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2024
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2023
1	Tuberculosis (Tuberculoses) 12/2022
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Lipodystrophy 02/2021
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 02/2021
1	Overweight 10/2019
1	Hypertension (High Blood Pressure) 10/2019
1	Abdominal Pain (Pain, Abdominal) 12/2018
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2017
1	Hairy Cell Leukemia 01/2015
1	Body Weight (Weight, Body) 07/2014
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2013

Drug/Important Bio-Agent (IBA)

10	Lipoproteins (Lipoprotein)IBA 04/2024 - 01/2010
10	LipidsIBA 01/2024 - 01/2010
7	CholesterolIBA 04/2024 - 11/2018
6	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2010
5	Peptides (Polypeptides)IBA 01/2023 - 10/2019
5	oxidized low density lipoproteinIBA 01/2023 - 01/2010
4	Apolipoprotein C-II (ApoC2)IBA 01/2023 - 01/2017
4	C-Reactive ProteinIBA 01/2023 - 11/2019
4	Apolipoproteins C (ApoC)IBA 02/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2023 - 10/2022
3	Colchicine FDA LinkGeneric 01/2023 - 11/2019
3	LDL CholesterolIBA 01/2023 - 01/2021
3	ApolipoproteinsIBA 01/2021 - 01/2010
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2014 - 01/2009
2	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2024 - 03/2024
2	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 03/2024
2	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 09/2020
2	Ketone BodiesIBA 03/2024 - 01/2024
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2023 - 02/2021
2	HDL LipoproteinsIBA 01/2022 - 11/2018
2	Insulin (Novolin)FDA Link 01/2022 - 09/2020
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 01/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 01/2010
2	HDL CholesterolIBA 01/2016 - 01/2010
2	CytokinesIBA 07/2014 - 01/2009
2	Proteins (Proteins, Gene)FDA Link 10/2010 - 01/2009
2	LigandsIBA 07/2009 - 04/2009
2	Toll-Like Receptor AgonistsIBA 04/2009 - 01/2009
1	Glycoproteins (Glycoprotein)IBA 04/2024
1	Alanine (L-Alanine)FDA Link 03/2024
1	Citric Acid (Citrate)FDA LinkGeneric 03/2024
1	Branched-Chain Amino AcidsIBA 03/2024
1	BilirubinIBA 01/2024
1	Lipoprotein-XIBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 01/2024
1	CarbonIBA 01/2023
1	TabletsIBA 01/2023
1	Lipoprotein(a)IBA 01/2023
1	Isoniazid (Ftivazide)FDA LinkGeneric 12/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	ResistinIBA 01/2022
1	VLDL CholesterolIBA 01/2022
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2022
1	metreleptinIBA 02/2021
1	LeptinIBA 02/2021
1	Apolipoproteins AIBA 02/2021
1	Angiopoietin-Like Protein 8IBA 02/2021
1	Apolipoprotein C-IIIIBA 02/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	Dietary Fats (Dietary Fat)IBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	Hormones (Hormone)IBA 10/2019
1	Proton Pump InhibitorsIBA 12/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2018
1	Drug CarriersIBA 11/2018
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 01/2016
1	Investigational DrugsIBA 01/2015

Therapy/Procedure

9	Therapeutics 09/2023 - 01/2009
1	Plasma Exchange 01/2020
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2020
1	Secondary Prevention 11/2019
1	Blood Component Removal (Apheresis) 07/2014
1	Hematopoietic Stem Cell Transplantation 09/2013